Dr. Mohan’s Diabetes Specialities Centre launches AI-driven Diabetic Retinopathy Screening
This initiative has been launched at the flagship clinics at Pondicherry and Thanjavur in the first phase of the rollout, with plans for expansion
Dr. Mohan’s Diabetes Specialities Centre (DMDSC) today an AI-driven Diabetic Retinopathy Screening Software. This initiative aims to harness the latest artificial intelligence technology to detect early-stage diabetic retinopathy and apply this technology to offer quick and precise analysis that aims to help doctors make informed decisions. Set to be available across its 50 clinics nationally, the hospital has launched this initiative in its flagship Pondicherry and Thanjavur clinics in the first phase of the rollout.
Diabetic retinopathy ranks among the primary causes of vision impairment in individuals with diabetes, frequently going unnoticed until substantial damage has taken place. With this AI-powered screening, DMDSC aims to bridge the gap between early detection and effective treatment by providing quick, highly accurate, and accessible diagnostic solutions.
This AI-driven screening uses a specialised camera and captures high-resolution retinal images, which are then analysed by sophisticated AI algorithms capable of detecting the earliest signs of retinal damage sooner than traditional methods. This automated process not only enhances accuracy but also empowers doctors with instant, data-driven insights.
- Advertisement -